MACQUARIE GROUP LTD - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$14,0000.0%5,294
-36.8%
0.00%
Q2 2022$14,000
-53.3%
8,3710.0%0.00%
Q1 2022$30,000
-28.6%
8,3710.0%0.00%
Q4 2021$42,000
-30.0%
8,3710.0%0.00%
Q3 2021$60,000
-23.1%
8,3710.0%0.00%
Q2 2021$78,0000.0%8,3710.0%0.00%
Q1 2021$78,000
+44.4%
8,371
+37.9%
0.00%
Q4 2020$54,000
-22.9%
6,0720.0%0.00%
Q3 2020$70,000
-57.3%
6,0720.0%0.00%
Q2 2020$164,0006,0720.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders